In addition, a recent pan-cancer analysis of 10 336 patients sequenced using MSK-IMPACT showed variability in the prevalence of TERT mutations across cancer types and found an association between the presence of TERT promoter mutations and higher tumor mutational burden (TMB) and neoantigen load. This evidence concerns the gene TERT and neoplasm.